Can cell therapy tackle hearing loss?

Beyond Biotech - the podcast from Labiotech

Labiotech에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Labiotech 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

6M ago 31:00

MP3•에피소드 홈

Hearing loss is a huge – and growing – global challenge.

Using its OSPREY platform, UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss, a significant global medical challenge.

The company’s lead asset, Rincell-1, is designed to regenerate auditory neurons and provide a novel treatment for patients with severe-to-profound age-related hearing loss or auditory neuropathy. The company is looking to start first-in-human trials in 2025.

Today, on the podcast we have a conversation with Rinri CEO Simon Chandler about the different kinds of hearing loss, what’s being done to tackle them, and Rinri’s novel approach to treatments.

01:08-03:19: About Rinri Therapeutics
03:19-05:16: About hearing loss
05:16-07:31: Mental health and hearing loss
07:31-10:22: The different kinds of hearing loss
10:22-11:37: The importance of early intervention
11:37-13:46: What is Rinri doing to tackle hearing loss?
13:46-15:58: The difficulty of accessing the cochlea
15:58-19:12: Is your treatment a cure for hearing loss?
19:12-20:45: Would repeat treatment be necessary?
20:45-23:30: Are other companies working on hearing loss?
23:30-25:27: The cost of treating hearing loss
25:27-27:13: The economic costs of hearing loss
27:13-28:33: Rinri treatment timelines
28:33-30:15: The rest of Rinri’s pipeline
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

챕터

1. Can cell therapy tackle hearing loss? (00:00:00)

2. About Rinri Therapeutics  (00:01:08)

3. About hearing loss (00:03:19)

4. Mental health and hearing loss  (00:05:16)

5. The different kinds of hearing loss (00:07:31)

6. The importance of early intervention  (00:10:22)

7. What is Rinri doing to tackle hearing loss?  (00:11:37)

8. The difficulty of accessing the cochlea  (00:13:46)

9. Is your treatment a cure for hearing loss?  (00:15:58)

10. Would repeat treatment be necessary?  (00:19:12)

11. Are other companies working on hearing loss?  (00:20:45)

12. The cost of treating hearing loss  (00:23:30)

13. The economic costs of hearing loss  (00:25:27)

14. Rinri treatment timelines  (00:27:13)

15. The rest of Rinri’s pipeline  (00:28:33)

125 에피소드

#News #Tech News #Labiotech